Delayed-type hypersensitivity (DTH) is an immune response in which previously sensitized T cells recognize an antigen and cause local inflammation, either by activating other immune cells or by directly damaging antigen-bearing cells. A classic reaction becomes evident after approximately 24–48 hours and is often most pronounced at 48–72 hours, although timing varies with the antigen, tissue, and clinical setting. Unlike antibody-mediated hypersensitivity, it does not depend primarily on antibodies. DTH is conventionally classified as type IV hypersensitivity, although that category also includes T-cell-mediated reactions with mechanisms and time courses broader than classical DTH.
Immunological basis
DTH is a manifestation of adaptive immunity. Its antigen specificity and capacity to recur depend on immunological memory. The underlying mechanisms can help control intracellular pathogens, but they can also injure surrounding tissue or produce disease in response to otherwise harmless substances.
The delay reflects the time needed for antigen recognition, inflammatory signaling, recruitment of circulating cells, and activation of local effector mechanisms. It is not simply a slower version of immediate allergy. Immediate allergic reactions typically involve immunoglobulin E, mast cells, and mediators such as histamine, whereas classical DTH is predominantly cellular.
Sensitization
During initial exposure, an antigen-presenting cell, often a dendritic cell, acquires antigen and presents antigen-derived peptides to T cells. Recognition usually involves a T-cell receptor interacting with a peptide bound to a major histocompatibility complex molecule. Appropriate costimulatory signals and the local cytokine environment support T-cell activation, proliferation, and differentiation.
Some activated T cells persist as memory cells, including cells resident in peripheral tissues. Sensitization may occur without an obvious clinical reaction. Small contact allergens can act as haptens, becoming immunogenic through association with host proteins; some substances, including metal ions, interact with immune recognition pathways in other ways.
Elicitation
On subsequent exposure, antigen-specific memory T cells become activated and initiate an inflammatory response. In classical DTH, CD4-positive type 1 helper T cells produce cytokines, particularly interferon-gamma, that activate macrophages and promote further cellular recruitment.
Activated macrophages help control pathogens but can also damage tissue through inflammatory mediators, enzymes, and reactive molecules. CD8-positive cytotoxic T cells contribute in many settings by killing target cells, including through mechanisms that induce apoptosis. The relative contributions of these pathways differ among diseases.
Tissue changes and clinical manifestations
A classical cutaneous DTH reaction produces redness and induration, a firm swelling caused by cellular infiltration and changes in the surrounding tissue. The infiltrate typically contains T lymphocytes and monocytes or macrophages. Unlike the rapidly developing wheal of an immediate skin reaction, the DTH lesion develops over many hours.
Its appearance depends on the tissue and stimulus:
- Localized antigen challenge can produce a circumscribed, indurated skin reaction.
- Contact allergy commonly produces an itchy, eczematous eruption, sometimes with vesicles.
- Persistent antigen exposure can sustain macrophage activation and contribute to granuloma formation.
- Cytotoxic T-cell responses can cause prominent injury to epithelial or other target cells.
A delayed clinical onset alone does not establish DTH. Other inflammatory and immune processes can also develop slowly.
Major examples
Tuberculin skin reaction
The tuberculin skin test is the classical clinical demonstration of DTH. Intradermal injection of purified protein derivative can elicit a local reaction in a person with prior cellular sensitization to relevant mycobacterial antigens. The response is generally assessed 48–72 hours later by measuring induration rather than redness.
A positive response indicates immunological sensitization; it does not by itself establish active tuberculosis. Previous BCG vaccination and exposure to some nontuberculous mycobacteria can affect interpretation. Conversely, some infected people have a negative reaction, particularly when cellular immune responsiveness is impaired.
Allergic contact dermatitis
Allergic contact dermatitis is a common T-cell-mediated reaction to substances contacting the skin. Examples include nickel, certain fragrance ingredients, rubber chemicals, and urushiol from poison ivy and related plants.
It differs from irritant contact dermatitis, which results from direct damage to the skin barrier rather than antigen-specific sensitization. Both conditions can produce similar-looking eruptions and can coexist.
Persistent infection and other immune injury
DTH-associated mechanisms contribute to host defense and tissue injury during some persistent infections. Continued stimulation can produce granulomatous inflammation, although granulomas are not specific to DTH and have multiple possible causes.
T-cell-mediated mechanisms also participate in some drug reactions, autoimmune diseases, and transplant rejection. These conditions are not uniformly examples of classical DTH: several immune pathways may operate together.
Relationship to type IV hypersensitivity
The Gell–Coombs classification, introduced in 1963, distinguished type IV reactions from three predominantly antibody-mediated categories. Modern descriptions sometimes divide type IV hypersensitivity into mechanistic subtypes:
| Subtype | Predominant mechanism |
|---|---|
| IVa | Type 1 helper T-cell signaling and macrophage activation |
| IVb | Type 2 helper T-cell signaling with eosinophilic inflammation |
| IVc | Cytotoxic T-cell-mediated tissue injury |
| IVd | T-cell-driven recruitment and activation of neutrophils |
Classical tuberculin-type DTH most closely corresponds to type IVa. These subdivisions are descriptive rather than completely separate biological categories: a single reaction may involve more than one pathway.
Diagnostic use and limitations
DTH mechanisms underlie several diagnostic procedures, but these procedures measure different aspects of cellular immunity.
Patch testing assesses delayed contact allergy by applying selected substances to the skin and examining reactions at specified later intervals. A positive reaction demonstrates contact sensitization under the test conditions; its relevance to a particular dermatitis depends on exposure and clinical context.
Intradermal antigen testing, including the tuberculin test, measures a local recall response. Its result depends on antigen-specific memory, immune function, and technical factors.
Interferon-gamma release assays measure antigen-stimulated cytokine release by blood cells. They assess cellular sensitization without producing a cutaneous DTH lesion and are therefore not direct measurements of a skin reaction.
A diminished or absent response may reflect lack of sensitization, impaired cellular immunity, or methodological limitations. Neither the presence nor the size of a DTH reaction is a universal measure of overall immune competence. Tissue findings likewise require context: a lymphocyte-rich inflammatory infiltrate alone does not identify the responsible antigen or establish a specific diagnosis.